GALDERMA LABS LP FDA Approval NDA 021112

NDA 021112

GALDERMA LABS LP

FDA Drug Application

Application #021112

Documents

Letter2012-12-26
Letter2013-01-28
Label2002-01-18
Label2014-04-01
Letter2014-04-02
Label2013-01-22
Review2002-03-26

Application Sponsors

NDA 021112GALDERMA LABS LP

Marketing Status

Prescription001

Application Products

001CREAM;TOPICAL0.01%;4%;0.05%1TRI-LUMAFLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN

FDA Submissions

TYPE 4; Type 4 - New CombinationORIG1AP2002-01-18STANDARD
LABELING; LabelingSUPPL6AP2013-01-16UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2013-07-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2013-10-18STANDARD
LABELING; LabelingSUPPL9AP2014-03-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2014-11-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP2015-01-20STANDARD

Submissions Property Types

SUPPL6Null6
SUPPL7Null0
SUPPL8Null0
SUPPL9Null6
SUPPL10Null0
SUPPL11Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21112
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.